AMD and Retinal Disease Journal Articles

• Complications of Retinopathy of Prematurity Treatment A new review highlights the potential complications associated with laser ablation and anti-VEGF injections for retinopathy of prematurity.
  Current Opinion in Ophthalmology, October 04, 2021
• Procalcitonin in Diagnosing Diabetic Foot Osteomyelitis Could measurements of serum procalcitonin levels help determine the presence of diabetic foot osteomyelitis?
  Wounds, September 10, 2021
• Artificial Intelligence-Based Predictions in Neovascular AMD What role could artificial intelligence have in the clinical management of neovascular age-related macular degeneration?
  Current Opinion in Ophthalmology, September 03, 2021
• Hearing or Vision Loss, Dual Sensory Loss, and Cognitive Decline This study aimed to elucidate the roles of hearing loss, vision loss, and dual sensory loss as risk factors for cognitive decline.
  Journal of the American Geriatrics Society, June 18, 2021
• Hepatitis C Related Cognitive Impairment This study assessed the prevalence and predictors of HCV-related cognitive impairment. Can it be reversed by anti-viral therapy?
  Journal of Viral Hepatitis, June 15, 2021
• Novel Vitreous Substitutes in Vitreoretinal Surgery Learn more about the exiting role new vitreous substitutes may have in vitreoretinal surgery.
  Current Opinion in Ophthalmology, June 04, 2021
• Thyroid Eye Disease: Navigating the New Treatment Landscape Recent advancements have led to the development of novel targeted therapies for thyroid eye disease. Learn more about these treatment options.
  Journal of the Endocrine Society, June 04, 2021
• Fasting Glucose Variation Predicts Microvascular Risk Is there an association between glycemic variations and the development or progression of microvascular complications in type 2 diabetes?
  Journal of Clinical Endocrinology & Metabolism, May 10, 2021
• Photobiomodulation Therapy in ARMD Is photobiomodulation therapy an effective treatment option for exudative and nonexudative AMD?
  Current Opinion in Ophthalmology, May 05, 2021
• Vision Loss in Giant Cell Arteritis Treated With Tocilizumab A new study examines the incidence of vision loss among patients with giant cell arteritis during treatment with tocilizumab compared with conventional glucocorticoid therapy.
  Arthritis Research & Therapy, April 30, 2021
• Retinal Imaging Study Diagnoses in COVID-19 Are ocular signs and symptoms in COVID-19 under recognized? This patient presented with retinal lesions but no other symptoms of COVID-19.
  Journal of Medical Case Reports, March 11, 2021
• Cost-Related Nonadherence and Mortality in Chronic Disease How does nonadherence resulting from financial barriers contribute to mortality among patients with diabetes, cardiovascular disease, and hypertension?
  Preventing Chronic Disease, February 02, 2021
• Presbyopia-Correcting IOLs in Refractive Surgery Patients Presbyopia-correcting lenses are an option for those seeking glasses-free vision, but in which post-corneal refractive surgery patients should these be considered?
  Current Opinion in Ophthalmology, January 08, 2021
• Endophthalmitis After Cataract Surgery: An Update Endophthalmitis is a known but uncommon complication of cataract surgery. What have we recently learned about the prevention and management of this potentially serious condition?
  Current Opinion in Ophthalmology, December 25, 2020
• Eyeshot: Ocular Injuries Caused by TASER Pistols This article gives an overview of ocular injury patterns and prognosis after TASER injuries.
  European Heart Journal, December 23, 2020
• Drug-Induced Maculopathy Which drugs are associated with this ocular toxicity, and how are these maculopathies best diagnosed and treated?
  Current Opinion in Ophthalmology, December 21, 2020
• AI in Cornea, Refractive, and Cataract Surgery What benefits might AI technology bring to the field of ophthalmology? A new review looks at the role it may have in cornea, refractive, and cataract surgery.
  Current Opinion in Ophthalmology, September 29, 2020
• Discontinuation of Hydroxychloroquine in Older SLE Patients Hydroxychloroquine is an effective treatment for SLE, but long-term use may increase the risk for adverse events. At what point should discontinuation be considered?
  Arthritis Research & Therapy, September 23, 2020
• Pharmacological Agents to Improve Venous Leg Ulcer Healing Which pharmacological treatment options may benefit healing in venous leg ulcers?
  Wounds, September 04, 2020
• The Retina Revolution: Targeted Therapies and AI With advancements in AI technology and developing treatment options, the horizon of retinal care is expanding.
  Current Opinion in Ophthalmology, May 22, 2020